Henan Hengxing Science Q3 2026: Impairment Cuts, Margin Boost, & Investor Outlook
Henan Hengxing Science’s latest Q3 report reveals asset impairment, a renewed employee share‑plan, and a 5% margin boost—signaling strategic recalibration and future upside.
3 minutes to read